Resources

The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.

Showing 701 Results

Say GRACE! Principles for Observational Studies

Research critics often point to methodological weaknesses inherent in observational studies, coupled with the lack of standard principles to assess their quality, as practical limitations to their…

RCTs vs. Observational Studies?

Randomized controlled trials (RCTs) can be the best way to answer a particular health care question, but they don’t reflect the real world, explains Dr. Robert Dubois, chief science officer at the…

Why Observational Studies Matter

Next week, the Institute of Medicine (IOM), in conjunction with the Patient-Centered Outcomes Research Institute (PCORI), will be holding a two-day workshop on the use of observational studies in a…

NPC Examines CER as Health Reform Takes Hold

What's on the National Pharmaceutical Council's (NPC) radar for 2013? NPC President Dan Leonard takes a closer look at comparative effectiveness research (CER), state health exchanges and benefits,…

US v. Caronia: Related Resources

The 2nd U.S. Circuit Court of Appeals' recent decision on United States vs. Caronia raises a big question for the pharmaceutical industry: will the decision have broader applicability to comparative…

US v. Caronia and CER Communications

A landmark appeals court ruling could open the door for the pharmaceutical industry to discuss information about comparative effectiveness research (CER) results, even when the data examines off…